MedPath

Comparing response of Aprepitant and Ondansetron with only Aprepitant in Post operative nausea and vomiting in craniotomy patients.

Not Applicable
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2021/04/032588
Lead Sponsor
DEPARTMENT OF ANAESTHESIOLOGY AND CRITICAL CARE JNMC ALIGARH MUSLIM UNIVERSITY
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

American Society of Anesthesiologists(ASA) physical status I & II patients of either sex scheduled to undergo elective craniotomy under General Anaesthesia.

Exclusion Criteria

(1) Patients with a history of motion sickness or gastrointestinal disease.

(2) Patients receiving antiemetics within 24 hours before surgery, (except Dexamethasone).

(3) Patients with cardiovascular disease like coronary artery disease, hypertension, etc.

(4) Pulmonary disease like asthma, COPD, cor-pulmonale.

(5) Patients with neuro-muscular, hepatic or major renal disease.

(6) History of alcohol, drug abuse or smokers.

(7) History suggestive of hiatus hernia/GERD.

(8) GCS less than 13.Â

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To measure the incidence of Post-Operative Nausea and Vomiting during first 24 hours after surgery.Timepoint: 24 hours after surgery
Secondary Outcome Measures
NameTimeMethod
1.Severity of nausea and vomiting. <br/ ><br>2.Number of emetic episodes. <br/ ><br>3.Incidence of complete response. <br/ ><br>4.Patient Satisfaction Score. <br/ ><br>5.Timing of first dose of rescue anti emetic. <br/ ><br>6.Time to first emetic episode. <br/ ><br>7.Timing of first dose of rescue analgesic. <br/ ><br>8.Incidence of side effects. <br/ ><br>Timepoint: 24 hours
© Copyright 2025. All Rights Reserved by MedPath